Patent US4000299A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4000299A Expired / Lapsed US ⏱️ 0.0 years remaining

1-(Imidazol-1-yl)-1-[4-(4-chlorophenyl)phenoxy]-3,3-dimethylbutan-2-one, its salts and a process for their use

Assignee: Bayer AG
•
Filing: 1975-05-27
•
Granted: 1976-12-28
•
Expires: 1995-05-27
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 1-(Imidazol-1-yl)-1-[4-(4-chlorophenyl)phenoxy]-3,3-dimethylbutan-2-one possesses antimicrobial activity, in particular antimycotic activity. The compound is prepared through the condensation of imidazole with 1-chloro-1-[4-(4-chlorophenyl)phenoxy]-3,3-dimethylbutan-2-one.

Inventors

  • 👤 Wolfgang Kramer
  • 👤 Karl Heinz Buchel
  • 👤 Manfred Plempel

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 11:40
CPC Classifications
C; C07; C07D; C07D231/00; C07D231/02; C07D231/10; C07D231/12; A; A61; A61P; A61P31/00; A61P31/04; A61P31/10; C07C; C07C45/00; C07C45/61; C07C45/67; C07C45/68; C07C45/70; C07C45/71; C07C49/00; C07C49/20; C07C49/255; C07D233/00; C07D233/54; C07D233/56; C07D249/00; C07D249/02; C07D249/08

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 18 words
A compound selected from the group consisting of 1-(imidazol-1-yl)-1-[4-(4-chlorophenyl)phenoxy]-3,3-dimethylbutan-2-one and the pharmaceutically acceptable nontoxic acid addition salts thereof.
Claim 2
Dependent Claim 18 words
A compound selected from the group consisting of 1-(imidazol-1-yl)-1-[4-(4-chlorophenyl)phenoxy]-3,3-dimethylbutan-2-one and the pharmaceutically acceptable nontoxic acid addition salts thereof.
Claim 3
Dependent Claim 9 words
The compound according to claim 1 which is 1-(imidazol-1-yl)-1-[4-(4-chlorophenyl)phenoxy]-3,3-dimethylbutan-2-one.
Claim 4
Dependent Claim 37 words
A compound according to claim 1 which is the salt of said 1-(imidazol-1-yl)-1- [4-(4-chlorophenyl)phenoxy]-3,3-dimethylbutan-2-one with a hydrogen halide acid, phosphoric acid, sulfuric acid, nitric acid, a sulfonic acid, a monobasic carboxylic acid or a dibasic carboxylic acid.
Claim 5
Dependent Claim 9 words
The compound of claim 1 which is 1-(imidazol-1-yl)-1-[4-(4-chlorophenyl)phenoxy]-3,3-dimethylbutan-2-one hydrochloride.
Claim 6
Dependent Claim 9 words
The compound of claim 1 which is 1-(imidazol-1-yl)-1-[4-(4-chlorophenyl)phenoxy]-3,3-dimethylbutan-2-one nitrate.
Claim 7
Dependent Claim 9 words
The compound of claim 1 which is 1-(imidazol-1-yl)-1-[4-(4-chlorophenyl)phenoxy]-3,3-dimethylbutan-2-one phosphate.
Claim 8
Dependent Claim 9 words
The compound of claim 1 which is 1-(imidazol-1-yl)-1-[4-(4-chlorophenyl)phenoxy]-3,3-dimethylbutan-2-one sulfate.
Claim 9
Dependent Claim 9 words
The compound of claim 1 which is 1-(imidazol-1-yl)-1-[4-(4-chlorophenyl)phenoxy]-3,3-dimethylbutan-2-one oxalate.
Claim 10
Dependent Claim 29 words
The method of combatting microbial infections in humans and animals which comprises administering to said human or animal an antimicrobially effective amount of a compound according to claim 1.
Claim 11
Dependent Claim 23 words
A pharmaceutical composition comprising an antimicrobially effective amount of a compound according to claim 1 in combination with a pharmaceutical carrier or diluent.

References Cited (Backward Citations)

DE2105490A1 Cited
US3812142A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1979-12-28 1980-06-28 1980-12-28 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1983-12-28 1984-06-28 1984-12-28 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1987-12-28 1988-06-28 1988-12-28 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag